scholarly journals Developing a model for estimating the activity of colonic microbes after intestinal surgeries

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0253542
Author(s):  
Andrew Marcus ◽  
Taylor L. Davis ◽  
Bruce E. Rittmann ◽  
John K. DiBaise ◽  
Elvis A. Carnero ◽  
...  

Background The large intestine provides a compensatory role in energy recovery when surgical interventions such as extensive small intestinal resections or bypass operations lower the efficiency of nutrient absorption in the upper gastrointestinal (GI) tract. While microorganisms in the colon are known to play vital roles in recovering energy, their contributions remain to be qualified and quantified in the small intestine resection. Objective We develop a mathematical model that links nutrient absorption in the upper and lower GI tract in two steps. Methods First, we describe the effects of small intestine resection on the ileocecal output (ICO), which enters the colon and provides food for microbes. Second, we describe energy recovered by the colon’s microorganisms via short-chain fatty acid (SCFA) production. We obtain model parameters by performing a least-squares regression analysis on clinical data for subjects with normal physiology and those who had undergone small intestine resection. Results For subjects with their intestines intact, our model provided a metabolizable energy value that aligns well with the traditional Atwater coefficients. With removal of the small intestine, physiological absorption became less efficient, and the metabolizable energy decreased. In parallel, the inefficiencies in physiological absorption by the small intestine are partly compensated by production of short-chain fatty acids (SCFA) from proteins and carbohydrates by microorganisms in the colon. The colon recovered more than half of the gross energy intake when the entire small intestine was removed. Meanwhile, the quality of energy absorbed changed, because microbe-derived SCFAs, not the original components of food, become the dominant form of absorbed energy. Conclusion The mathematical model developed here provides an important framework for describing the effect of clinical interventions on the colon’s microorganisms.

Nutrients ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 1297 ◽  
Author(s):  
Ravichandra Vemuri ◽  
Rohit Gundamaraju ◽  
Tanvi Shinde ◽  
Agampodi Promoda Perera ◽  
Waheedha Basheer ◽  
...  

Distribution of the microbiota varies according to the location in the gastrointestinal (GI) tract. Thus, dysbiosis during aging may not be limited to faecal microbiota and extend to the other parts of the GI tract, especially the cecum and colon. Lactobacillus acidophilus DDS-1, a probiotic strain, has been shown to modulate faecal microbiota and its associated metabolic phenotype in aging mice. In the present study, we investigated the effect of L. acidophilus DDS-1 supplementation on caecal- and mucosal-associated microbiota, short-chain fatty acids (SCFAs) and immunological profiles in young and aging C57BL/6J mice. Besides differences in the young and aging control groups, we observed microbial shifts in caecal and mucosal samples, leading to an alteration in SCFA levels and immune response. DDS-1 treatment increased the abundances of beneficial bacteria such as Akkermansia spp. and Lactobacillus spp. more effectively in caecal samples than in mucosal samples. DDS-1 also enhanced the levels of butyrate, while downregulating the production of inflammatory cytokines (IL-6, IL-1β, IL-1α, MCP-1, MIP-1α, MIP-1β, IL-12 and IFN-γ) in serum and colonic explants. Our findings suggest distinct patterns of intestinal microbiota, improvements in SCFA and immunological profiles with DDS-1 supplementation in aging mice.


Endocrinology ◽  
2013 ◽  
Vol 154 (10) ◽  
pp. 3552-3564 ◽  
Author(s):  
Mark K. Nøhr ◽  
Maria H. Pedersen ◽  
Andreas Gille ◽  
Kristoffer L. Egerod ◽  
Maja S. Engelstoft ◽  
...  

The expression of short-chain fatty acid receptors GPR41/FFAR3 and GPR43/ free fatty acid receptor 2 (FFAR2) was studied in the gastrointestinal tract of transgenic monomeric red fluorescent protein (mRFP) reporter mice. In the stomach free fatty acid receptor 3 (FFAR3)-mRFP was expressed in a subpopulation of ghrelin and gastrin cells. In contrast, strong expression of FFAR3-mRFP was observed in all cholecystokinin, glucose-dependent insulinotropic peptide (GIP), and secretin cells of the proximal small intestine and in all glucagon-like peptide-1 (GLP-1), peptide YY, and neurotensin cells of the distal small intestine. Throughout the colon and rectum, FFAR3-mRFP was strongly expressed in the large population of peptide YY and GLP-1 cells and in the neurotensin cells of the proximal colon. A gradient of expression of FFAR3-mRFP was observed in the somatostatin cells from less than 5% in the stomach to more than 95% in the rectum. Substance P-containing enterochromaffin cells displayed a similar gradient of FFAR3-mRFP expression throughout the small intestine. Surprisingly, FFAR3-mRFP was also expressed in the neuronal cells of the submucosal and myenteric ganglia. Quantitative PCR analysis of fluorescence-activated cell sorting (FACS) purified FFAR3-mRFP positive cells confirmed the coexpression with the various peptide hormones as well as key neuronal marker proteins. The FFAR2-mRFP reporter was strongly expressed in a large population of leukocytes in the lamina propria of in particular the small intestine but surprisingly only weakly in a subpopulation of enteroendocrine cells. Nevertheless, synthetic ligands specific for either FFAR3 or FFAR2 each released GLP-1 from colonic crypt cultures and the FFAR2 agonist mobilized intracellular Ca2+ in FFAR2 positive enteroendocrine cells. It is concluded that FFAR3-mRFP serves as a useful marker for the majority of enteroendocrine cells of the small and large intestine and that FFAR3 and FFAR2 both act as sensors for short-chain fatty acids in enteroendocrine cells, whereas FFAR3 apparently has this role alone in enteric neurons and FFAR2 in enteric leukocytes.


2010 ◽  
Vol 55 (No. 6) ◽  
pp. 264-274 ◽  
Author(s):  
D. Mista ◽  
J. Piekarska ◽  
M. Houszka ◽  
W. Zawadzki ◽  
M. Gorczykowski

The influence of short chain fatty acids (SCFA) on histopathological changes in the small intestine and the intensity of invasion of T. spiralis in mice were investigated in this study. The animals were infected with doses of 500 and 250 T. spiralis larvae per mouse. A SCFA solution containing acetic, propionic and butyric acid (30 : 15 : 20mM) was administered orally to the mice starting from the 5<sup>th</sup> day before infection to the 20<sup>th</sup> day after infection (day). Fragments of the jejunum collected during dissection on the 7th and 10th day were used to prepare specimens to assess the histopathological changes. In the infected animals, the intestinal trichinellae were counted on the 7<sup>th</sup> and 10<sup>th</sup> day, while on the 42<sup>nd</sup> day the muscle larvae number were determined. The strongest host reaction in the intestine was observed on the 7<sup>th</sup> day at a dose of T. spiralis 500 larvae, and on the 10<sup>th</sup> day at a dose of 250 larvae. Numerous inflammatory infiltrations, strong shortening of the intestinal villi, extension of the intestinal crypts, and the lowest ratio of the villi length to the intestinal crypts depth were observed. The ratio was 1.3 &plusmn; 0.3 on the 7<sup>th</sup> day at a dose of 500 larvae, and on the 10<sup>th</sup> day, at dose of 250 larvae the ratio reached 1.5 &plusmn; 0.5. Both values differed significantly from the control group: 3.3 &plusmn; 0.5 (P &lt; 0.01). Administration of SCFA to the animals infected with T. spiralis caused remission of local histopathological changes resulting from the presence of the parasite in the small intestine after the mentioned periods. This manifested as limited villi shortening and reduced deepening of intestinal crypts. At the higher infectious dose, in animals receiving the acid solution, on the 7<sup>th</sup> day the intestinal villi were considerably longer (356 &micro;m &plusmn; 35) than in the group infected with T. spiralis but not treated with the acids (279 &micro;m &plusmn; 57; P &lt; 0.01). At a lower dose of parasites, on the 10<sup>th</sup> day these values were 339 &micro;m &plusmn; 88 and 306 &micro;m &plusmn; 47 respectively and the observed differences were not statistically significant. The solution of SCFA also caused a decrease in the numbers of mature parasites in the intestine and the muscle larvae at a dose of 500 larvae/mouse. In animals receiving the SCFA, 24 050 &plusmn; 10 415 larvae were observed in muscles, while in the infected mice, which did not receive the acids, 32 875 &plusmn; 16 762 larvae were detected (P &lt; 0.05). An increase in the intensity of infection accelerated the rate of host reaction to the presence of T. spiralis in the intestines (self-cure). To summarize, the administered solution of short chain fatty acids alleviated the formation of histopathological changes in the intestine in response to the parasite's presence, and lowered the intensity of T. spiralis invasion after infection with a higher dose of larvae. &nbsp;


1998 ◽  
Vol 128 (6) ◽  
pp. 947-953 ◽  
Author(s):  
Hetty M. G. van Beers-Schreurs ◽  
Marius J. A. Nabuurs ◽  
Liebe Vellenga, ◽  
Hilda J. Kalsbeek-van der Valk ◽  
Theo Wensing ◽  
...  

1999 ◽  
Vol 43 (4) ◽  
pp. 950-953 ◽  
Author(s):  
Mariana Gontijo Ramos ◽  
Eduardo Alves Bambirra ◽  
Jacques Robert Nicoli ◽  
Denise Carmona Cara ◽  
Enio Cardillo Vieira ◽  
...  

ABSTRACT In germfree mice, the administration of short-chain fatty acids (SCFA) protected the intestinal mucosa from damage produced by 1-β-d-arabinofuranosylcytosine (Ara-C). Animals receiving SCFA and Ara-C had intestinal morphologies closer to normal than the control animals, which had severe intestinal lesions. We concluded that orally administrated SCFA reduce intestinal lesions, improving the mucosa pattern of the small intestine and colon.


1994 ◽  
Vol 92 (4) ◽  
pp. 629-635 ◽  
Author(s):  
Mercedes Gallardo ◽  
Paloma Munoz De Rueda ◽  
Angel Jesus Matilla ◽  
Isabel Maria Sanchez-Calle

Sign in / Sign up

Export Citation Format

Share Document